Witnessing the stock’s movement on the chart, on Thursday, Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) set off with pace as it heaved 2.48% to $2.07, before settling in for the price of $2.02 at the close. Taking a more long-term approach, RVPH posted a 52-week range of $0.60-$4.83.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 0.00%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 40.26%. This publicly-traded company’s shares outstanding now amounts to $46.58 million, simultaneously with a float of $41.63 million. The organization now has a market capitalization sitting at $96.42 million. At the time of writing, stock’s 50-day Moving Average stood at $1.79, while the 200-day Moving Average is $1.48.
Reviva Pharmaceuticals Holdings Inc (RVPH) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Reviva Pharmaceuticals Holdings Inc’s current insider ownership accounts for 10.62%, in contrast to 28.91% institutional ownership.
Reviva Pharmaceuticals Holdings Inc (RVPH) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.23 per share during the current fiscal year.
Reviva Pharmaceuticals Holdings Inc’s EPS increase for this current 12-month fiscal period is 40.26% and is forecasted to reach -0.84 in the upcoming year.
Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) Trading Performance Indicators
Let’s observe the current performance indicators for Reviva Pharmaceuticals Holdings Inc (RVPH). It’s Quick Ratio in the last reported quarter now stands at 0.39. The Stock has managed to achieve an average true range (ATR) of 0.21.
In the same vein, RVPH’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.11, a figure that is expected to reach -0.21 in the next quarter, and analysts are predicting that it will be -0.84 at the market close of one year from today.
Technical Analysis of Reviva Pharmaceuticals Holdings Inc (RVPH)
Going through the that latest performance of [Reviva Pharmaceuticals Holdings Inc, RVPH]. Its last 5-days volume of 1.29 million was inferior to the volume of 2.18 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 83.64% While, its Average True Range was 0.19.
Raw Stochastic average of Reviva Pharmaceuticals Holdings Inc (RVPH) in the period of the previous 100 days is set at 34.96%, which indicates a major fall in contrast to 82.98% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 64.31% that was lower than 145.84% volatility it exhibited in the past 100-days period.
